BRPI0922716A2 - purificação de polipeptídeo - Google Patents
purificação de polipeptídeoInfo
- Publication number
- BRPI0922716A2 BRPI0922716A2 BRPI0922716A BRPI0922716A BRPI0922716A2 BR PI0922716 A2 BRPI0922716 A2 BR PI0922716A2 BR PI0922716 A BRPI0922716 A BR PI0922716A BR PI0922716 A BRPI0922716 A BR PI0922716A BR PI0922716 A2 BRPI0922716 A2 BR PI0922716A2
- Authority
- BR
- Brazil
- Prior art keywords
- polypeptide purification
- polypeptide
- purification
- Prior art date
Links
- 229920001184 polypeptide Polymers 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 238000000746 purification Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/18—Ion-exchange chromatography
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6437—Coagulation factor VIIa (3.4.21.21)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21021—Coagulation factor VIIa (3.4.21.21)
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP08170454 | 2008-12-02 | ||
| PCT/EP2009/066149 WO2010063717A1 (en) | 2008-12-02 | 2009-12-01 | Polypeptide purification |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0922716A2 true BRPI0922716A2 (pt) | 2016-11-01 |
Family
ID=40404199
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0922716A BRPI0922716A2 (pt) | 2008-12-02 | 2009-12-01 | purificação de polipeptídeo |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20110287518A1 (pt) |
| EP (1) | EP2373677B1 (pt) |
| JP (1) | JP5788803B2 (pt) |
| KR (1) | KR101821143B1 (pt) |
| CN (1) | CN102239175A (pt) |
| AU (1) | AU2009324204B2 (pt) |
| BR (1) | BRPI0922716A2 (pt) |
| CA (1) | CA2742246A1 (pt) |
| ES (1) | ES2576109T3 (pt) |
| MX (1) | MX2011005474A (pt) |
| RU (1) | RU2544860C2 (pt) |
| WO (1) | WO2010063717A1 (pt) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3715356B1 (en) * | 2009-12-18 | 2023-10-11 | CSL Limited | Method of purifying polypeptides |
| EP2526115B1 (en) | 2010-01-18 | 2018-08-01 | Novo Nordisk Health Care AG | Purification of blood coagulation factors |
| JP6147726B2 (ja) | 2011-03-29 | 2017-06-14 | グラクソスミスクライン・リミテッド・ライアビリティ・カンパニーＧｌａｘｏＳｍｉｔｈＫｌｉｎｅ ＬＬＣ | タンパク質精製のためのバッファー系 |
| RU2014108241A (ru) | 2011-08-25 | 2015-09-27 | Ф.Хоффманн-Ля Рош Аг | Способ катион- и анионобменной хроматографии |
| CA2976875A1 (en) | 2015-02-25 | 2016-09-01 | Omrix Biopharmaceuticals Ltd. | Method for purifying and quantifying thrombin and its degradation polypeptides |
| WO2016207328A1 (en) * | 2015-06-24 | 2016-12-29 | Glycotope Gmbh | PROCESS FOR THE PURIFICATION OF γ-CARBOXYLATED POLYPEPTIDES |
| AU2017295037B2 (en) * | 2016-07-15 | 2021-07-22 | F. Hoffmann-La Roche Ag | Method for purifying PEGylated erythropoietin |
| CN114599971A (zh) * | 2019-10-14 | 2022-06-07 | 皮尔斯生物科技有限公司 | 肽纯化配制物和方法 |
| JP7855344B2 (ja) * | 2021-12-17 | 2026-05-08 | Ｋｍバイオロジクス株式会社 | ビタミンＫ依存性タンパク質のγ－カルボキシグルタミン酸修飾度の分析方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4981952A (en) | 1988-10-04 | 1991-01-01 | Eli Lilly And Company | Method for the purification of vitamin K-dependent proteins |
| IT1262899B (it) | 1992-03-27 | 1996-07-22 | Sclavo Spa | Processo per l'isolamento di fattore ix, fattore x e fattore ii altamente purificati dal complesso protrombinico o dal plasma umano |
| AU2004221758B2 (en) * | 2003-03-18 | 2010-07-22 | Novo Nordisk Health Care Ag | Method for the production of GLA-residue containing serine proteases |
| JP2008525381A (ja) * | 2004-12-23 | 2008-07-17 | ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト | 関心のあるビタミンｋ依存性タンパク質を含んでなる組成物中におけるタンパク質混入物の量の減少 |
| DK2125866T3 (da) * | 2007-02-28 | 2013-07-29 | Baxter Int | Fremgangsmåde til rensning af rekombinant blodkoagulationsfaktor IX, som er beriget med sulfaterede og/eller phosphorylerede molekyler |
-
2009
- 2009-12-01 CA CA2742246A patent/CA2742246A1/en not_active Abandoned
- 2009-12-01 MX MX2011005474A patent/MX2011005474A/es active IP Right Grant
- 2009-12-01 WO PCT/EP2009/066149 patent/WO2010063717A1/en not_active Ceased
- 2009-12-01 US US13/131,757 patent/US20110287518A1/en not_active Abandoned
- 2009-12-01 RU RU2011125656/04A patent/RU2544860C2/ru active
- 2009-12-01 CN CN2009801490787A patent/CN102239175A/zh active Pending
- 2009-12-01 JP JP2011538995A patent/JP5788803B2/ja active Active
- 2009-12-01 KR KR1020117014183A patent/KR101821143B1/ko not_active Expired - Fee Related
- 2009-12-01 EP EP09793497.0A patent/EP2373677B1/en active Active
- 2009-12-01 ES ES09793497.0T patent/ES2576109T3/es active Active
- 2009-12-01 BR BRPI0922716A patent/BRPI0922716A2/pt not_active Application Discontinuation
- 2009-12-01 AU AU2009324204A patent/AU2009324204B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| JP2012510500A (ja) | 2012-05-10 |
| EP2373677B1 (en) | 2016-03-23 |
| EP2373677A1 (en) | 2011-10-12 |
| CN102239175A (zh) | 2011-11-09 |
| RU2011125656A (ru) | 2013-01-10 |
| JP5788803B2 (ja) | 2015-10-07 |
| KR101821143B1 (ko) | 2018-01-23 |
| ES2576109T3 (es) | 2016-07-05 |
| AU2009324204B2 (en) | 2014-10-16 |
| WO2010063717A1 (en) | 2010-06-10 |
| AU2009324204A1 (en) | 2010-06-10 |
| US20110287518A1 (en) | 2011-11-24 |
| RU2544860C2 (ru) | 2015-03-20 |
| CA2742246A1 (en) | 2010-06-10 |
| MX2011005474A (es) | 2011-06-16 |
| KR20110099251A (ko) | 2011-09-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NL300879I2 (nl) | Alirocumab | |
| BRPI0919237A2 (pt) | purificação de policarbonatos | |
| BRPI0921327A2 (pt) | Combinação de herbicida-protetor | |
| BRPI0907457A2 (pt) | Absorventes | |
| BRPI0906764A2 (pt) | Processos | |
| EP2406399A4 (en) | MIRAC PROTEINS | |
| EP2420634A4 (en) | CONNECTOR | |
| EP2344029A4 (en) | Electrode system | |
| EP2305405A4 (en) | COATED ELEMENT | |
| BRPI0914649A2 (pt) | Piprazolo-quinazolinas | |
| DE602008003521D1 (de) | Sitzrücklehnungsmechanismus | |
| DK2598514T3 (da) | Proteinoprensning | |
| FI8206U1 (fi) | Kanylointisimulantti | |
| BRPI0813830A2 (pt) | Purificação de polipeptídeos peguilados | |
| BRPI0923541A2 (pt) | purificação de imunoglobulina | |
| BRPI0907522A2 (pt) | biarlamidas | |
| EP2259958A4 (en) | LINKAGE | |
| BRPI1010661A2 (pt) | peptídeo | |
| DE112009000183A5 (de) | Sicherheitsvorreiber | |
| BR112012006603A2 (pt) | braçadeira de fixação | |
| BRPI0909634A2 (pt) | 2-aminoquinolinas | |
| BRPI0922728A2 (pt) | combinação de herbicida-antídoto | |
| BRPI0909637A2 (pt) | 2-aminoquinolinas | |
| BRPI0907863A2 (pt) | pirrolopirimidinacarboxamidas | |
| EP2221104A4 (en) | CLEANING CATALYST |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B25G | Requested change of headquarter approved |
Owner name: NOVO NORDISK HEALTH CARE AG (CH) |
|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
| B10A | Cessation: cessation confirmed |